Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins. [electronic resource]
Producer: 20090921Description: 407-12 p. digitalISSN:- 1879-355X
- Aged
- Androgen Antagonists -- therapeutic use
- Buserelin -- therapeutic use
- Combined Modality Therapy -- methods
- Humans
- Imidazolidines -- therapeutic use
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- blood
- Neoplasm Staging
- Neoplasm, Residual
- Pilot Projects
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatectomy
- Prostatic Neoplasms -- drug therapy
- Regression Analysis
- Survival Rate
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.